Favorable Outcomes in CLL Pts with Alternate Kinase Inhibitors Following Ibrutinib or Idelalisib Discontinuation: Results from a Large Multi-Center Study
Resource Type
Abstract
Authors
Mato, Anthony ; Nabhan, Chadi ; Barr, Paul M. ; Ujjani, Chaitra S. ; Hill, Brian T. ; Lamanna, Nicole ; Skarbnik, Alan P ; Howlett, Christina ; Pu, Jeffrey J ; Sehgal, Alison R. ; Strelec, Lauren E. ; Vandegrift, Alexandra ; Rago, Allison ; Zent, Clive S ; Feldman, Tatyana ; Goy, Andre ; Claxton, David F. ; Bachow, Spencer Henick ; Kaur, Gurbakhash ; Svoboda, Jakub ; Dwivedy Nasta, Sunita ; Porter, David ; Landsburg, Daniel J. ; Schuster, Stephen J. ; Cheson, Bruce D. ; Evens, Andrew M.
Source
In Blood 3 December 2015 126(23):719-719
Subject
Language
ISSN
0006-4971